ThinkstockAt a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming under more scrutiny, Pfizer Inc. (NYSE:PFE) announced on Monday that the Federal…
Jon C. Ogg A new research note from Jefferies lists stocks that could have meaningful events soon. The stocks in some cases have sold off significantly, and the analysts view fundamental downside as limited.
The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical stocks, short interest decreased.
24/7 Wall St. maintains on its watch list a slew of defensive dividend stocks that investors flock to during periods of uncertainty. The trick is to know which companies are appropriate at…
thinkstockAugust 6, 2015: Markets opened higher again on Thursday but not by much and equities quickly turned south and remained in the red for the rest of the day. The report on…
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well for investors this year. At the end of 2014 Savita Subramanian and…
Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy stocks after…
thinkstockJuly 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s 8.5% dive. U.S. consumer confidence came in lower than expected and home…
ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted earnings per share (EPS) of $0.56 and revenues of $11.9 billion. In…
Paul Ausick Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company is expected to post earnings per share (EPS) of $0.52 on revenues…
Paul Ausick ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for investors now.
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
